BETA nonprofit public democratic european moderated

Search

#ResearchAndDevelopment

Deputy Minister of Development Stavros Kalafatis highlighted that Greece produces a significant portion of Europe's oncology (50%), cardio-metabolic (30%), and penicillin (25%) drugs, emphasizing the importance of collaboration between the state, industry, and research sectors in driving innovation and sustainable growth within the healthcare industry. #InnovationInHealthcare #PharmaceuticalIndustry #ResearchAndDevelopment

Kalafatis: Greece produces 50% of Europe’s oncology drugs, 30% of cardio-metabolic drugs and 25% of penicillin drugs

(TR) AstraZeneca invests increasingly more in research and development in Poland. The scale of AstraZeneca's involvement shows that Poland remains an attractive place for conducting research and development activities. Its expenditures on R&D in Poland reached approximately 800 million in 2025.

Nothing (Original: 🇨🇳 #China’s A-share listed companies have been steadily ramping up research and development spending, with innovation resources increasingly flowing into sectors such as new energy, semiconductors, chips and biopharmaceutical, the Securities Times reports. ➡ More than 5,500 https://t.co/BjC0qUYW2N) #Innovation #ResearchAndDevelopment #ChinaEconomy #CN